In the last trading session, 1.55 million shares of the BioAffinity Technologies Inc (NASDAQ:BIAF) were traded, and its beta was 2.70. Most recently the company’s share price was $0.26, and it changed around -$0.02 or -4.87% from the last close, which brings the market valuation of the company to $7.14M. BIAF currently trades at a discount to its 52-week high of $2.99, offering almost -1050.0% off that amount. The share price’s 52-week low was $0.16, which indicates that the current value has risen by an impressive 38.46% since then.
BioAffinity Technologies Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BIAF as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Instantly BIAF has showed a red trend with a performance of -4.87% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3200 on recent trading dayincreased the stock’s daily price by 18.75%. The company’s shares are currently down -71.22% year-to-date, but still up 23.71% over the last five days. On the other hand, BioAffinity Technologies Inc (NASDAQ:BIAF) is -48.85% down in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.71%.
BIAF Dividends
BioAffinity Technologies Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 220.23 shares worth $57677.0, making up 0.81% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 69.47 shares worth around $18193.0, which represents about 0.25% of the total shares outstanding.
